EMA Authorised: Memantine Accord (memantine hydrochloride) — Accord Healthcare S.L.U.

View source ↗

Summary

EMA authorised Memantine Accord (memantine hydrochloride) for the treatment of Alzheimer’s disease. The product is marketed by Accord Healthcare S.L.U.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine Accord (memantine hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Alzheimer Disease. MAH: Accord Healthcare S.L.U.. Decision date: 08/10/2025